Cargando…

Scripted spot removal in PBS proton therapy planning

BACKGROUND: It is well known in proton therapy that the relative biological effectiveness (RBE) is not constant across the entire Bragg peak, with higher RBE at the distal end of the Bragg peak due to higher linear energy transfer (LET). Treatment planning systems are moving toward LET optimization...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedrick, Samantha G., Walker, Bryant, Morris, Bart, Petro, Scott, Blakey, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833280/
https://www.ncbi.nlm.nih.gov/pubmed/34890101
http://dx.doi.org/10.1002/acm2.13491
_version_ 1784648897015054336
author Hedrick, Samantha G.
Walker, Bryant
Morris, Bart
Petro, Scott
Blakey, Marc
author_facet Hedrick, Samantha G.
Walker, Bryant
Morris, Bart
Petro, Scott
Blakey, Marc
author_sort Hedrick, Samantha G.
collection PubMed
description BACKGROUND: It is well known in proton therapy that the relative biological effectiveness (RBE) is not constant across the entire Bragg peak, with higher RBE at the distal end of the Bragg peak due to higher linear energy transfer (LET). Treatment planning systems are moving toward LET optimization to mitigate this potentially higher biological impact at a track end. However, using a simple script, proton users can begin to simulate this process by deleting spots from critical structures during optimization. In most cases, nominal target coverage and plan robustness remain satisfactory. METHODS: In our clinic, we developed a script that allows the user to delete spots in all organs at risk (OARs) of interest for one or more treatment beams. The purpose of this script is to potentially reduce side effects by eliminating Bragg peaks within OARs. The script was first used for prostate patients where spots in the rectum and sigmoid, outside of the overlap with the target, were deleted. We then began to use the script for head and neck (H&N) and breast/chestwall patients to reduce acute side effects of the skin by removing spots in a 0.5‐cm skin rind. CONCLUSIONS: By utilizing a simple script for deleting spots in critical structures, we have seen excellent clinical results thus far. We have noted reduced skin reactions for nearly all H&N and breast patients.
format Online
Article
Text
id pubmed-8833280
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88332802022-02-14 Scripted spot removal in PBS proton therapy planning Hedrick, Samantha G. Walker, Bryant Morris, Bart Petro, Scott Blakey, Marc J Appl Clin Med Phys Technical Notes BACKGROUND: It is well known in proton therapy that the relative biological effectiveness (RBE) is not constant across the entire Bragg peak, with higher RBE at the distal end of the Bragg peak due to higher linear energy transfer (LET). Treatment planning systems are moving toward LET optimization to mitigate this potentially higher biological impact at a track end. However, using a simple script, proton users can begin to simulate this process by deleting spots from critical structures during optimization. In most cases, nominal target coverage and plan robustness remain satisfactory. METHODS: In our clinic, we developed a script that allows the user to delete spots in all organs at risk (OARs) of interest for one or more treatment beams. The purpose of this script is to potentially reduce side effects by eliminating Bragg peaks within OARs. The script was first used for prostate patients where spots in the rectum and sigmoid, outside of the overlap with the target, were deleted. We then began to use the script for head and neck (H&N) and breast/chestwall patients to reduce acute side effects of the skin by removing spots in a 0.5‐cm skin rind. CONCLUSIONS: By utilizing a simple script for deleting spots in critical structures, we have seen excellent clinical results thus far. We have noted reduced skin reactions for nearly all H&N and breast patients. John Wiley and Sons Inc. 2021-12-10 /pmc/articles/PMC8833280/ /pubmed/34890101 http://dx.doi.org/10.1002/acm2.13491 Text en © 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Technical Notes
Hedrick, Samantha G.
Walker, Bryant
Morris, Bart
Petro, Scott
Blakey, Marc
Scripted spot removal in PBS proton therapy planning
title Scripted spot removal in PBS proton therapy planning
title_full Scripted spot removal in PBS proton therapy planning
title_fullStr Scripted spot removal in PBS proton therapy planning
title_full_unstemmed Scripted spot removal in PBS proton therapy planning
title_short Scripted spot removal in PBS proton therapy planning
title_sort scripted spot removal in pbs proton therapy planning
topic Technical Notes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833280/
https://www.ncbi.nlm.nih.gov/pubmed/34890101
http://dx.doi.org/10.1002/acm2.13491
work_keys_str_mv AT hedricksamanthag scriptedspotremovalinpbsprotontherapyplanning
AT walkerbryant scriptedspotremovalinpbsprotontherapyplanning
AT morrisbart scriptedspotremovalinpbsprotontherapyplanning
AT petroscott scriptedspotremovalinpbsprotontherapyplanning
AT blakeymarc scriptedspotremovalinpbsprotontherapyplanning